An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 12 , ISSUE 3 ( September-December, 2020 ) > List of Articles

RESEARCH ARTICLE

Vitamin D Influence on the Clinical Course of Benign Paroxysmal Positional Vertigo: A Retrospective Cohort Study

Seyit M Ceylan, Mahmut A Kanmaz

Keywords : Logistic regression, Recurrence of BPPV, The effect of age, Vitamin D administration

Citation Information :

DOI: 10.5005/jp-journals-10003-1359

License: CC BY-NC 4.0

Published Online: 00-12-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim and objective: This retrospective cohort study was designed to investigate the possible relationship between vitamin D and the clinical course of benign paroxysmal positional vertigo (BPPV). Materials and methods: The medical records of patients admitted to a tertiary health center between January 2017 and December 2018 were retrospectively reviewed. Ninety idiopathic BPPV and one hundred healthy subjects without vertigo were included in the study. Results: The serum vitamin D concentration and BPPV occurrence were not correlated (p = 0.601). BPPV recurrence was significantly affected by age (p = 0.028) and serum vitamin D concentrations (p = 0.02). Conclusion: This study indicated that there is no causal relationship between low vitamin D levels and BPPV. Another result of the study is that low vitamin D concentrations and older age increase BPPV recurrences. This increase in recurrence due to vitamin D deficiency does not eliminate oral vitamin D treatment. Clinical significance: The relationship between vitamin D and BPPV is still controversial and the effect of vitamin D administration on the BPPV treatment process is unknown.


PDF Share
  1. Von Brevern M, Bertholon P, Brandt T, et al. Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res 2015;25(3–4):105–117. DOI: 10.3233/VES-150553.
  2. Von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population-based study. J Neurol Neurosurg Psychiatry 2007;78(7):710–715. DOI: 10.1136/jnnp.2006.100420.
  3. Kim JS, Zee DS. Clinical practice. Benign paroxysmal positional vertigo. N Engl J Med 2014;370(12):1138–1147. DOI: 10.1056/NEJMcp1309481.
  4. Yang CJ, Kim Y, Lee HS, et al. Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. J Vestib Res 2018;27(5–6):287–294. DOI: 10.3233/VES-170625.
  5. Jeong SH, Kim JS, Shin JW, et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 2013;260(3):832–838. 10.1007/s00415-012-6712-2.
  6. Buki B, Ecker M, Junger H, et al. Vitamin D deficiency and benign paroxysmal positioning vertigo. Med Hypotheses 2013;80(2):201–204. DOI: 10.1016/j.mehy.2012.11.029.
  7. Rhim GI. Serum vitamin D and recurrent benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol 2016;1(6):150–153. DOI: 10.1002/lio2.35.
  8. Parham K, Leonard G, Feinn RS. Prospective clinical investigation of the relationship between idiopathic benign paroxysmal positional vertigo and bone turnover: a pilot study. Laryngoscope 2013;123(11):2834–2839. DOI: 10.1002/lary.24162.
  9. Karatas A, Acar YG, Yuce T, et al. Association of benign paroxysmal positional vertigo with osteoporosis and vitamin D deficiency: a case-controlled study. J Int Adv Otol 2017;13(2):259–265. DOI: 10.5152/iao.2016.2640.
  10. Cıkrıkcı Isık G, Cevik Y, Emektar E, et al. Analysis of vitamin D and calcium levels in benign paroxysmal positional vertigo. Eurasian J Emerg Med 2017;16:128–132. DOI: 10.5152/eajem.2017.58077.
  11. Maslovara S, Butkovic Soldo S, Sestak A, et al. 25 (OH) D3 levels, incidence and recurrence of different clinical forms of BPPV. Braz J Otorhinolaryngol 2018;84(4):453–459. DOI: 10.1016/j.bjorl.2017.05.007.
  12. Yamauchi D, Raveendran NN, Pondugula SR, et al. Vitamin D up-regulates the expression of ECaC1 mRNA in semicircular canal. Biochem Biophys Res Commun 2005;331(4):1353–1357. DOI: 10.1016/j.bbrc.2005.04.053.
  13. AlGarni MA, Mirza AA, Althobaiti AA, et al. Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2018;275(11):2705–2711. DOI: 10.1007/s00405-018-5146-6.
  14. Han W, Fan Z, Zhou M, et al. Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo. Acta Otolaryngol 2018;138(5):443–446. DOI: 10.1080/00016489.2017.1416168.
  15. Talaat HS, Abuhadied G, Talaat AS, et al. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol 2015;272(9):2249–2253. DOI: 10.1007/s00405-014-3175-3.
  16. Talaat HS, Kabel AH, Khaliel LH, et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx 2016;43(3):237–241. DOI: 10.1016/j.anl.2015.08.009.
  17. Chen G, Li Y, Si J, et al. Treatment and recurrence of traumatic versus idiopathic benign paroxysmal positional vertigo: a meta-analysis. Acta Otolaryngol 2019;139(9):727–733. DOI: 10.1080/00016489.2019.1632484.
  18. De Stefano A, Dispenza F, Suarez H, et al. A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx 2014;41(1):31–36. DOI: 10.1016/j.anl.2013.07.007.
  19. Kim SY, Han SH, Kim YH, et al. Clinical features of recurrence and osteoporotic changes in benign paroxysmal positional vertigo. Auris Nasus Larynx 2017;44(2):156–161. DOI: 10.1016/j.anl.2016.06.006.
  20. Sempos CT, Vesper HW, Phinney KW, et al. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012;243:32–40. DOI: 10.3109/00365513.2012.681935.
  21. Cashman KD, Kiely M. Towards prevention of vitamin D deficiency and beyond: knowledge gaps and research needs in vitamin D nutrition and public health. Br J Nutr 2011;106(11):1617–1627. DOI: 10.1017/S0007114511004995.
  22. Cashman KD, Dowling KG, Skrabakova Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 2016;103(4):1033–1044. DOI: 10.3945/ajcn.115.120873.
  23. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169(4):384–390. DOI: 10.1001/archinternmed.2008.560.
  24. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010;5(6):11088. DOI: 10.1371/journal.pone.0011088.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.